{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T03:54:35Z","timestamp":1793850875712,"version":"4.6.1"},"reference-count":85,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004410","name":"Scientific and Technological Research Council of Turkey","doi-asserted-by":"publisher","award":["122Z163"],"award-info":[{"award-number":["122Z163"]}],"id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004410","name":"Scientific and Technological Research Council of Turkey","doi-asserted-by":"publisher","award":["118Z167"],"award-info":[{"award-number":["118Z167"]}],"id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004410","name":"European Molecular Biology Organization","doi-asserted-by":"publisher","award":["4162"],"award-info":[{"award-number":["4162"]}],"id":[{"id":"10.13039\/100004410","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Molecular Medicine"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.molmed.2024.02.002","type":"journal-article","created":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T16:13:17Z","timestamp":1709568797000},"page":"471-483","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Ectodysplasin A2 receptor signaling in skeletal muscle pathophysiology"],"prefix":"10.1016","volume":"30","author":[{"given":"Sevgi D\u00f6nd\u00fc","family":"\u00d6zen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8722-9913","authenticated-orcid":false,"given":"Serkan","family":"Kir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmed.2024.02.002_bb0005","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1002\/oby.23227","article-title":"Skeletal muscle energy metabolism in obesity","volume":"29","author":"Mengeste","year":"2021","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.molmed.2024.02.002_bb0010","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/s42255-020-0251-4","article-title":"Skeletal muscle energy metabolism during exercise","volume":"2","author":"Hargreaves","year":"2020","journal-title":"Nat. Metab."},{"key":"10.1016\/j.molmed.2024.02.002_bb0015","doi-asserted-by":"crossref","first-page":"327","DOI":"10.4093\/dmj.2017.41.5.327","article-title":"Skeletal muscle thermogenesis and its role in whole body energy metabolism","volume":"41","author":"Periasamy","year":"2017","journal-title":"Diabetes Metab. J."},{"key":"10.1016\/j.molmed.2024.02.002_bb0020","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/23328940.2017.1328999","article-title":"Shivering thermogenesis in humans: origin, contribution and metabolic requirement","volume":"4","author":"Haman","year":"2017","journal-title":"Temperature (Austin)"},{"key":"10.1016\/j.molmed.2024.02.002_bb0025","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.3390\/ijms24032973","article-title":"Prevalence and mechanisms of skeletal muscle atrophy in metabolic conditions","volume":"24","author":"Jun","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.molmed.2024.02.002_bb0030","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/s41580-021-00389-z","article-title":"Molecular and cellular basis of genetically inherited skeletal muscle disorders","volume":"22","author":"Dowling","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.molmed.2024.02.002_bb0035","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.tem.2021.03.007","article-title":"Cancer-mediated muscle cachexia: etiology and clinical management","volume":"32","author":"Siff","year":"2021","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.molmed.2024.02.002_bb0040","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/s41586-023-06047-y","article-title":"EDA2R-NIK signalling promotes muscle atrophy linked to cancer cachexia","volume":"617","author":"Bilgic","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2024.02.002_bb0045","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1038\/nm.4420","article-title":"A microRNA screen reveals that elevated hepatic ectodysplasin A expression contributes to obesity-induced insulin resistance in skeletal muscle","volume":"23","author":"Awazawa","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2024.02.002_bb0050","doi-asserted-by":"crossref","unstructured":"Barbera, M.C. et al. (2021) Increased expression of ectodysplasin A2 receptor EDA2R is the most remarkable and ubiquitous aging-related transcriptional hallmark. Published online Augus4, 2021. https:\/\/doi.org\/10.21203\/rs.3.rs-774469\/v1","DOI":"10.21203\/rs.3.rs-774469\/v1"},{"key":"10.1016\/j.molmed.2024.02.002_bb0055","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1152\/physrev.00045.2017","article-title":"The TNF family of ligands and receptors: communication modules in the immune system and beyond","volume":"99","author":"Dostert","year":"2019","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.molmed.2024.02.002_bb0060","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1186\/1471-2164-12-602","article-title":"Muscle wasting and the temporal gene expression pattern in a novel rat intensive care unit model","volume":"12","author":"Llano-Diez","year":"2011","journal-title":"BMC Genomics"},{"key":"10.1016\/j.molmed.2024.02.002_bb0065","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.10528","article-title":"Transcriptional activator TAp63 is upregulated in muscular atrophy during ALS and induces the pro-atrophic ubiquitin ligase Trim63","volume":"5","author":"von Grabowiecki","year":"2016","journal-title":"eLife"},{"key":"10.1016\/j.molmed.2024.02.002_bb0070","first-page":"9393","article-title":"Single nuclei profiling identifies cell specific markers of skeletal muscle aging, frailty, and senescence","volume":"14","author":"Perez","year":"2022","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.molmed.2024.02.002_bb0075","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1248\/bpb.b12-00741","article-title":"Macrophage migration inhibitory factor is a possible candidate for the induction of microalbuminuria in diabetic db\/db mice","volume":"36","author":"Watanabe","year":"2013","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.molmed.2024.02.002_bb0080","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/nrd4467","article-title":"Muscle wasting in disease: molecular mechanisms and promising therapies","volume":"14","author":"Cohen","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.molmed.2024.02.002_bb0085","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.tips.2023.07.006","article-title":"Muscle wasting: emerging pathways and potential drug targets","volume":"44","author":"Domaniku","year":"2023","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.molmed.2024.02.002_bb0090","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/978-981-13-1435-3_10","article-title":"Ubiquitin-proteasome pathway and muscle atrophy","volume":"1088","author":"Khalil","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.molmed.2024.02.002_bb0095","doi-asserted-by":"crossref","first-page":"E469","DOI":"10.1152\/ajpendo.00204.2014","article-title":"Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx\/atrogin-1","volume":"307","author":"Bodine","year":"2014","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.molmed.2024.02.002_bb0100","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1146\/annurev-pharmtox-010818-021041","article-title":"Muscle wasting diseases: novel targets and treatments","volume":"59","author":"Furrer","year":"2019","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.molmed.2024.02.002_bb0105","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21134759","article-title":"Signaling pathways that control muscle mass","volume":"21","author":"Vainshtein","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.molmed.2024.02.002_bb0110","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S1097-2765(04)00211-4","article-title":"The IGF-1\/PI3K\/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors","volume":"14","author":"Stitt","year":"2004","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molmed.2024.02.002_bb0115","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/978-981-13-1435-3_6","article-title":"The role of IGF-1 signaling in skeletal muscle atrophy","volume":"1088","author":"Timmer","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.molmed.2024.02.002_bb0120","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.3390\/cells11172671","article-title":"Transforming growth factor-beta signaling in cancer-induced cachexia: from molecular pathways to the clinics","volume":"11","author":"Balsano","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.molmed.2024.02.002_bb0125","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/s41577-021-00624-w","article-title":"The interplay of immunology and cachexia in infection and cancer","volume":"22","author":"Baazim","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.molmed.2024.02.002_bb0130","doi-asserted-by":"crossref","first-page":"E410","DOI":"10.1152\/ajpendo.00039.2012","article-title":"JAK\/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia","volume":"303","author":"Bonetto","year":"2012","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.molmed.2024.02.002_bb0135","doi-asserted-by":"crossref","first-page":"19976","DOI":"10.1074\/jbc.M115.638411","article-title":"A key role for leukemia inhibitory factor in C26 cancer cachexia","volume":"290","author":"Seto","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2024.02.002_bb0140","article-title":"Activated oncostatin M signaling drives cancer-associated skeletal muscle wasting","author":"Domaniku","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.molmed.2024.02.002_bb0145","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41577-018-0066-7","article-title":"Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer","volume":"18","author":"Jones","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.molmed.2024.02.002_bb0150","doi-asserted-by":"crossref","first-page":"11177","DOI":"10.1074\/jbc.M115.641514","article-title":"Inhibition of Stat3 activation suppresses caspase-3 and the ubiquitin-proteasome system, leading to preservation of muscle mass in cancer cachexia","volume":"290","author":"Silva","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2024.02.002_bb0155","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.788411","article-title":"Ectodysplasin A\/ectodysplasin A receptor system and their roles in multiple diseases","volume":"12","author":"Cai","year":"2021","journal-title":"Front. Physiol."},{"key":"10.1016\/j.molmed.2024.02.002_bb0160","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1128\/MCB.24.4.1608-1613.2004","article-title":"Myodegeneration in EDA-A2 transgenic mice is prevented by XEDAR deficiency","volume":"24","author":"Newton","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.molmed.2024.02.002_bb0165","doi-asserted-by":"crossref","first-page":"E743","DOI":"10.1073\/pnas.1714703115","article-title":"Fenofibrate prevents skeletal muscle loss in mice with lung cancer","volume":"115","author":"Goncalves","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.molmed.2024.02.002_bb0170","article-title":"Tumor-induced alterations in single-nucleus transcriptome of atrophying muscles indicate enhanced protein degradation and reduced oxidative metabolism","author":"Agca","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.molmed.2024.02.002_bb0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022538","article-title":"STAT3 activation in skeletal muscle links muscle wasting and the acute phase response in cancer cachexia","volume":"6","author":"Bonetto","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.molmed.2024.02.002_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2022.155972","article-title":"Exogenous oncostatin M induces cardiac dysfunction, musculoskeletal atrophy, and fibrosis","volume":"159","author":"Jengelley","year":"2022","journal-title":"Cytokine"},{"key":"10.1016\/j.molmed.2024.02.002_bb0185","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.bbrc.2019.06.143","article-title":"Oncostatin M induces C2C12 myotube atrophy by modulating muscle differentiation and degradation","volume":"516","author":"Miki","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.molmed.2024.02.002_bb0190","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1152\/physiolgenomics.00022.2013","article-title":"Altered gene expression patterns in muscle ring finger 1 null mice during denervation- and dexamethasone-induced muscle atrophy","volume":"45","author":"Furlow","year":"2013","journal-title":"Physiol. Genomics"},{"key":"10.1016\/j.molmed.2024.02.002_bb0195","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1002\/jcsm.13023","article-title":"Decoding the transcriptome of denervated muscle at single-nucleus resolution","volume":"13","author":"Lin","year":"2022","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"key":"10.1016\/j.molmed.2024.02.002_bb0200","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/path.2097","article-title":"Morphology, mechanisms and pathology of musculoskeletal ageing","volume":"211","author":"Freemont","year":"2007","journal-title":"J. Pathol."},{"key":"10.1016\/j.molmed.2024.02.002_bb0205","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.18632\/aging.101262","article-title":"Aging and sarcopenia associate with specific interactions between gut microbes, serum biomarkers and host physiology in rats","volume":"9","author":"Siddharth","year":"2017","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.molmed.2024.02.002_bb0210","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/s43587-022-00250-8","article-title":"Characterization of cellular senescence in aging skeletal muscle","volume":"2","author":"Zhang","year":"2022","journal-title":"Nat. Aging"},{"key":"10.1016\/j.molmed.2024.02.002_bb0215","doi-asserted-by":"crossref","first-page":"21391","DOI":"10.18632\/aging.103885","article-title":"Aging-related changes in the gene expression profile of human lungs","volume":"12","author":"Jeong","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.molmed.2024.02.002_bb0220","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1136\/thoraxjnl-2017-210074","article-title":"Lung tissue gene-expression signature for the ageing lung in COPD","volume":"73","author":"de Vries","year":"2017","journal-title":"Thorax"},{"key":"10.1016\/j.molmed.2024.02.002_bb0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0237006","article-title":"RNAAgeCalc: a multi-tissue transcriptional age calculator","volume":"15","author":"Ren","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.molmed.2024.02.002_bb0230","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s11357-013-9583-2","article-title":"Satellite cells in human skeletal muscle; from birth to old age","volume":"36","author":"Verdijk","year":"2014","journal-title":"Age (Dordr.)"},{"key":"10.1016\/j.molmed.2024.02.002_bb0235","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1038\/s41591-019-0673-2","article-title":"Undulating changes in human plasma proteome profiles across the lifespan","volume":"25","author":"Lehallier","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2024.02.002_bb0240","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.917113","article-title":"Diabetic muscular atrophy: molecular mechanisms and promising therapies","volume":"13","author":"Shen","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.molmed.2024.02.002_bb0245","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.biochi.2020.04.003","article-title":"EDA2R mediates podocyte injury in high glucose milieu","volume":"174","author":"Lan","year":"2020","journal-title":"Biochimie"},{"key":"10.1016\/j.molmed.2024.02.002_bb0250","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1681\/ASN.2017101112","article-title":"Lipoxins regulate the early growth response-1 network and reverse diabetic kidney disease","volume":"29","author":"Brennan","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.molmed.2024.02.002_bb0255","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.642432","article-title":"Ectodysplasin A is increased in non-alcoholic fatty liver disease, but is not associated with type 2 diabetes","volume":"12","author":"Bayliss","year":"2021","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.molmed.2024.02.002_bb0260","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.cca.2019.09.009","article-title":"Circulating ectodysplasin A is a potential biomarker for nonalcoholic fatty liver disease","volume":"499","author":"Yang","year":"2019","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.molmed.2024.02.002_bb0265","doi-asserted-by":"crossref","first-page":"44953","DOI":"10.1074\/jbc.M207923200","article-title":"Role of TRAF3 and -6 in the Activation of the NF-\u03baB and JNK Pathways by X-linked ectodermal dysplasia receptor","volume":"277","author":"Sinha","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2024.02.002_bb0270","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1126\/science.290.5491.523","article-title":"Two-amino acid molecular switch in an epithelial morphogen that regulates binding to two distinct receptors","volume":"290","author":"Yan","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.molmed.2024.02.002_bb0275","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.bbrc.2015.08.019","article-title":"XEDAR activates the non-canonical NF-\u03baB pathway","volume":"465","author":"Verhelst","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.molmed.2024.02.002_bb0280","doi-asserted-by":"crossref","first-page":"41873","DOI":"10.1074\/jbc.M407363200","article-title":"Induction of apoptosis by X-linked ectodermal dysplasia receptor via a caspase 8-dependent mechanism","volume":"279","author":"Sinha","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2024.02.002_bb0285","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1038\/onc.2009.154","article-title":"XEDAR as a putative colorectal tumor suppressor that mediates p53-regulated anoikis pathway","volume":"28","author":"Tanikawa","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.molmed.2024.02.002_bb0290","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1016\/j.febslet.2010.04.058","article-title":"p53-dependent transcriptional regulation of EDA2R and its involvement in chemotherapy-induced hair loss","volume":"584","author":"Brosh","year":"2010","journal-title":"FEBS Lett."},{"key":"10.1016\/j.molmed.2024.02.002_bb0295","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.13014","article-title":"Glucocorticoids increase skeletal muscle NF-\u03baB inducing kinase (NIK): links to muscle atrophy","volume":"4","author":"Fry","year":"2016","journal-title":"Physiol. Rep."},{"key":"10.1016\/j.molmed.2024.02.002_bb0300","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.1210\/en.2011-1343","article-title":"NF-\u03baB-inducing kinase (NIK) mediates skeletal muscle Insulin Resistance: Blockade by Adiponectin","volume":"152","author":"Choudhary","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.molmed.2024.02.002_bb0305","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1007\/s10753-023-01820-7","article-title":"NF-\u03baB-inducing kinase provokes insulin resistance in skeletal muscle of obese mice","volume":"46","author":"Chen","year":"2023","journal-title":"Inflammation"},{"key":"10.1016\/j.molmed.2024.02.002_bb0310","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.molmed.2019.02.005","article-title":"NIK as a druggable mediator of tissue injury","volume":"25","author":"Valino-Rivas","year":"2019","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.molmed.2024.02.002_bb0315","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.930986","article-title":"The therapeutic potential of targeting NIK in B cell malignancies","volume":"13","author":"Haselager","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molmed.2024.02.002_bb0320","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1096\/fj.201600840R","article-title":"A small-molecule inhibitor of NF-kappaB-inducing kinase (NIK) protects liver from toxin-induced inflammation, oxidative stress, and injury","volume":"31","author":"Ren","year":"2017","journal-title":"FASEB J."},{"key":"10.1016\/j.molmed.2024.02.002_bb0325","doi-asserted-by":"crossref","first-page":"3579","DOI":"10.7150\/thno.40149","article-title":"NIK links inflammation to hepatic steatosis by suppressing PPAR\u03b1 in alcoholic liver disease","volume":"10","author":"Li","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.molmed.2024.02.002_bb0330","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1016\/j.ymthe.2020.07.016","article-title":"Activation of NF-\u03baB-inducing kinase in islet \u03b2 cells causes \u03b2 cell failure and diabetes","volume":"28","author":"Li","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.molmed.2024.02.002_bb0335","doi-asserted-by":"crossref","first-page":"4388","DOI":"10.1021\/acs.jmedchem.0c00396","article-title":"Discovery of a potent and selective NF-\u03baB-inducing kinase (NIK) inhibitor that has anti-inflammatory effects in vitro and in vivo","volume":"63","author":"Li","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.molmed.2024.02.002_bb0340","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/s41467-017-02672-0","article-title":"NF-kappaB inducing kinase is a therapeutic target for systemic lupus erythematosus","volume":"9","author":"Brightbill","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2024.02.002_bb0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2020.115316","article-title":"A novel inhibitor of NF-kappaB-inducing kinase prevents bone loss by inhibiting osteoclastic bone resorption in ovariectomized mice","volume":"135","author":"Takakura","year":"2020","journal-title":"Bone"},{"key":"10.1016\/j.molmed.2024.02.002_bb0350","doi-asserted-by":"crossref","first-page":"6748","DOI":"10.1021\/acs.jmedchem.0c00055","article-title":"Identification of N-phenyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine derivatives as novel, potent, and selective NF-kappaB inducing kinase (NIK) inhibitors for the treatment of psoriasis","volume":"63","author":"Zhu","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.molmed.2024.02.002_bb0355","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.taap.2016.07.005","article-title":"Mangiferin, a novel nuclear factor kappa B-inducing kinase inhibitor, suppresses metastasis and tumor growth in a mouse metastatic melanoma model","volume":"306","author":"Takeda","year":"2016","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.molmed.2024.02.002_bb0360","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.201800374","article-title":"Identification of new NIK inhibitors by discriminatory analysis-based molecular docking and biological evaluation","volume":"352","author":"Cheng","year":"2019","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.molmed.2024.02.002_bb0365","doi-asserted-by":"crossref","first-page":"4515","DOI":"10.1016\/j.bmcl.2010.06.027","article-title":"NF-\u03baB inducing kinase (NIK) inhibitors: Identification of new scaffolds using virtual screening","volume":"20","author":"Mortier","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.molmed.2024.02.002_bb0370","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1039\/C8MD00068A","article-title":"N-Acetyl-3-aminopyrazoles block the non-canonical NF-kB cascade by selectively inhibiting NIK","volume":"9","author":"Pippione","year":"2018","journal-title":"Medchemcomm"},{"key":"10.1016\/j.molmed.2024.02.002_bb0375","doi-asserted-by":"crossref","first-page":"3756","DOI":"10.1182\/blood-2012-01-405951","article-title":"Hodgkin lymphoma requires stabilized NIK and constitutive RelB expression for survival","volume":"120","author":"Ranuncolo","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2024.02.002_bb0380","doi-asserted-by":"crossref","first-page":"4554","DOI":"10.18632\/oncotarget.2128","article-title":"Novel inhibitors are cytotoxic for myeloma cells with NFkB inducing kinase-dependent activation of NFkB","volume":"5","author":"Demchenko","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.molmed.2024.02.002_bb0385","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21145164","article-title":"Small Molecule NF-kappaB Pathway Inhibitors in Clinic","volume":"21","author":"Ramadass","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.molmed.2024.02.002_bb0390","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.716469","article-title":"NF-\u03baB: at the borders of autoimmunity and inflammation","volume":"12","author":"Barnabei","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molmed.2024.02.002_bb0395","article-title":"NF-\u03baB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.molmed.2024.02.002_bb0400","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.it.2022.07.004","article-title":"NF-\u03baB: blending metabolism, immunity, and inflammation","volume":"43","author":"Capece","year":"2022","journal-title":"Trends Immunol."},{"key":"10.1016\/j.molmed.2024.02.002_bb0405","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3390\/biomedicines5030050","article-title":"Unlocking the NF-\u03baB conundrum: embracing complexity to achieve specificity","volume":"5","author":"Begalli","year":"2017","journal-title":"Biomedicines"},{"key":"10.1016\/j.molmed.2024.02.002_bb0410","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.cytogfr.2014.01.004","article-title":"Ectodysplasin A (EDA) - EDA receptor signalling and its pharmacological modulation","volume":"25","author":"Kowalczyk-Quintas","year":"2014","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.molmed.2024.02.002_bb0415","article-title":"Ectodysplasin A (EDA) signaling: from skin appendage to multiple diseases","volume":"23","author":"Yang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.molmed.2024.02.002_bb0420","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/j.str.2003.11.009","article-title":"The crystal structures of EDA-A1 and EDA-A2: splice variants with distinct receptor specificity","volume":"11","author":"Hymowitz","year":"2003","journal-title":"Structure"},{"key":"10.1016\/j.molmed.2024.02.002_bb0425","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.tig.2013.08.006","article-title":"The ectodysplasin pathway: from diseases to adaptations","volume":"30","author":"Sadier","year":"2014","journal-title":"Trends Genet."}],"container-title":["Trends in Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491424000273?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491424000273?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T19:52:40Z","timestamp":1778615560000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471491424000273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":85,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S1471491424000273"],"URL":"https:\/\/doi.org\/10.1016\/j.molmed.2024.02.002","relation":{},"ISSN":["1471-4914"],"issn-type":[{"value":"1471-4914","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ectodysplasin A2 receptor signaling in skeletal muscle pathophysiology","name":"articletitle","label":"Article Title"},{"value":"Trends in Molecular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmed.2024.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}